Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-08-11 Sale | 2023-08-14 4:06 pm | Neoleukin Therapeutics Inc. | NLTX | Smith Sean Michael Interim CFO, Prin Acct Off | 1,323 | $0.6184 | $818 | 21,637 (Direct) | View |
| 2023-02-02 Sale | 2023-02-03 4:33 pm | Neoleukin Therapeutics Inc. | NLTX | Smith Sean Michael Principal Accounting Officer | 3,316 | $0.5972 | $1,980 | 28,460 (Direct) | View |
| 2022-08-10 Sale | 2022-08-12 5:24 pm | Neoleukin Therapeutics Inc. | NLTX | Smith Sean Michael Principal Accounting Officer | 1,655 | $0.9914 | $1,641 | 11,776 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-08-10 Exercise | 2023-08-14 4:06 pm | N/A N/A | Neoleukin Therapeutics Inc. | NLTX | Smith Sean Michael Interim CFO, Prin Acct Off | 5,000 | $0 | 21,637 (Direct) | View |
| 2023-02-01 Exercise | 2023-02-03 4:33 pm | N/A N/A | Neoleukin Therapeutics Inc. | NLTX | Smith Sean Michael Principal Accounting Officer | 12,500 | $0 | 28,460 (Direct) | View |
| 2022-08-10 Exercise | 2022-08-12 5:24 pm | N/A N/A | Neoleukin Therapeutics Inc. | NLTX | Smith Sean Michael Principal Accounting Officer | 5,000 | $0 | 11,776 (Direct) | View |
| 2022-08-02 Option Award | 2022-08-04 4:41 pm | N/A 2032-08-01 | Neoleukin Therapeutics Inc. | NLTX | Smith Sean Michael Principal Accounting Officer | 150,000 | $0 | 150,000 (Direct) | View |
| 2022-03-02 Option Award | 2022-03-03 4:39 pm | N/A 2032-03-01 | Neoleukin Therapeutics Inc. | NLTX | Smith Sean Michael Principal Accounting Officer | 80,000 | $0 | 80,000 (Direct) | View |
Ownership | 2022-03-03 4:38 pm | N/A N/A | Neoleukin Therapeutics Inc. | NLTX | Smith Sean Michael Principal Accounting Officer | 0 | $0 | 103,431 (Direct) | View |